Annual SGA
$10.24 M
+$167.00 K+1.66%
December 31, 2023
Summary
- As of February 6, 2025, TRVI annual SGA is $10.24 million, with the most recent change of +$167.00 thousand (+1.66%) on December 31, 2023.
- During the last 3 years, TRVI annual SGA has risen by +$79.00 thousand (+0.78%).
- TRVI annual SGA is now at all-time high.
Performance
TRVI SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.86 M
-$405.00 K-12.39%
September 30, 2024
Summary
- As of February 6, 2025, TRVI quarterly SGA is $2.86 million, with the most recent change of -$405.00 thousand (-12.39%) on September 30, 2024.
- Over the past year, TRVI quarterly SGA has increased by +$448.00 thousand (+18.55%).
- TRVI quarterly SGA is now -12.39% below its all-time high of $3.27 million, reached on June 30, 2024.
Performance
TRVI Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.03 B
-$44.32 M-4.51%
September 30, 2024
Summary
- As of February 6, 2025, TRVI TTM SGA is -$1.03 billion, with the most recent change of -$44.32 million (-4.51%) on September 30, 2024.
- Over the past year, TRVI TTM SGA has dropped by -$1.04 billion (-10131.13%).
- TRVI TTM SGA is now -838.09% below its all-time high of -$109.50 million.
Performance
TRVI TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TRVI Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.7% | +18.6% | -10000.0% |
| 3 y3 years | +0.8% | +28.4% | -10000.0% |
| 5 y5 years | +136.2% | +43.1% | -10000.0% |
TRVI Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.9% | -12.4% | +36.7% | -52.5% | at low |
| 5 y | 5-year | at high | +40.2% | -12.4% | +47.4% | -134.7% | at low |
| alltime | all time | at high | +378.1% | -12.4% | +267.5% | -838.1% | at low |
Trevi Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.86 M(-12.4%) | $11.65 M(+1.2%) |
| Jun 2024 | - | $3.27 M(+5.4%) | $11.51 M(+6.8%) |
| Mar 2024 | - | $3.10 M(+28.4%) | $10.78 M(+5.3%) |
| Dec 2023 | $10.24 M(+1.7%) | $2.42 M(-11.3%) | $10.24 M(+0.7%) |
| Sep 2023 | - | $2.72 M(+7.2%) | $10.16 M(+0.9%) |
| Jun 2023 | - | $2.54 M(-0.9%) | $10.08 M(-1.7%) |
| Mar 2023 | - | $2.56 M(+9.5%) | $10.26 M(+1.8%) |
| Dec 2022 | $10.07 M(+6.1%) | $2.34 M(-11.2%) | $10.07 M(+2.5%) |
| Sep 2022 | - | $2.64 M(-3.0%) | $9.83 M(+4.3%) |
| Jun 2022 | - | $2.72 M(+14.2%) | $9.42 M(+0.5%) |
| Mar 2022 | - | $2.38 M(+13.7%) | $9.37 M(-1.3%) |
| Dec 2021 | $9.49 M | $2.09 M(-6.1%) | $9.49 M(-5.4%) |
| Sep 2021 | - | $2.23 M(-16.5%) | $10.03 M(-1.8%) |
| Jun 2021 | - | $2.67 M(+6.8%) | $10.22 M(+1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $2.50 M(-5.1%) | $10.04 M(-1.2%) |
| Dec 2020 | $10.16 M(+39.1%) | $2.63 M(+9.0%) | $10.16 M(+7.3%) |
| Sep 2020 | - | $2.42 M(-3.0%) | $9.47 M(+4.6%) |
| Jun 2020 | - | $2.49 M(-4.9%) | $9.05 M(+7.1%) |
| Mar 2020 | - | $2.62 M(+34.8%) | $8.45 M(+15.7%) |
| Dec 2019 | $7.31 M(+68.5%) | $1.94 M(-2.9%) | $7.31 M(+7.9%) |
| Sep 2019 | - | $2.00 M(+5.9%) | $6.77 M(+13.2%) |
| Jun 2019 | - | $1.89 M(+28.2%) | $5.98 M(+18.8%) |
| Mar 2019 | - | $1.47 M(+4.8%) | $5.03 M(+16.0%) |
| Dec 2018 | $4.34 M(+102.4%) | $1.41 M(+16.2%) | $4.34 M(+48.0%) |
| Sep 2018 | - | $1.21 M(+28.6%) | $2.93 M(+70.3%) |
| Jun 2018 | - | $941.00 K(+20.8%) | $1.72 M(+120.8%) |
| Mar 2018 | - | $779.00 K | $779.00 K |
| Dec 2017 | $2.14 M | - | - |
FAQ
- What is Trevi Therapeutics annual SGA?
- What is the all time high annual SGA for Trevi Therapeutics?
- What is Trevi Therapeutics annual SGA year-on-year change?
- What is Trevi Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly SGA year-on-year change?
- What is Trevi Therapeutics TTM SGA?
- What is the all time high TTM SGA for Trevi Therapeutics?
- What is Trevi Therapeutics TTM SGA year-on-year change?
What is Trevi Therapeutics annual SGA?
The current annual SGA of TRVI is $10.24 M
What is the all time high annual SGA for Trevi Therapeutics?
Trevi Therapeutics all-time high annual SGA is $10.24 M
What is Trevi Therapeutics annual SGA year-on-year change?
Over the past year, TRVI annual SGA has changed by +$167.00 K (+1.66%)
What is Trevi Therapeutics quarterly SGA?
The current quarterly SGA of TRVI is $2.86 M
What is the all time high quarterly SGA for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly SGA is $3.27 M
What is Trevi Therapeutics quarterly SGA year-on-year change?
Over the past year, TRVI quarterly SGA has changed by +$448.00 K (+18.55%)
What is Trevi Therapeutics TTM SGA?
The current TTM SGA of TRVI is -$1.03 B
What is the all time high TTM SGA for Trevi Therapeutics?
Trevi Therapeutics all-time high TTM SGA is -$109.50 M
What is Trevi Therapeutics TTM SGA year-on-year change?
Over the past year, TRVI TTM SGA has changed by -$1.04 B (-10131.13%)